About us
Liaoning Pharmaceutical Foreign Trade Corporation was established in 1994 and is the holding company of Shanghai Pharmaceuticals Holding Co., Ltd. Our company is a comprehensive pharmaceutical distribution enterprise that integrates various business formats, such as pharmaceutical sales, device distribution and sales, e-commerce, in-depth promotion, import and export business, supply chain services, logistics services, emerging businesses and so on. In recent years, by continuously ascertaining development strategy, broadening horizons, consolidating management foundation, and innovating business mode, our company’s operating performance and business efficiency have become increasingly prominent in the industry, and we have been awarded the ” Credit AAA Rating” for several consecutive years; In the 2017 ” Statistical Analysis Report on the Operation of the Pharmaceutical Distribution Industry ” released by the Department of Market Supervision of the Ministry of Commerce, our company was ranked 41st in the National Top 100 Pharmaceutical Distribution Enterprises. In 2019, the sales of our company achieved 5.83 billion.
Business introduction
Company sales in 2018 were 4.66 billion
More than 4,200 terminal customers; have established long-term and stable business relationships with more than 100 foreign customers from more than 20 countries and regions.
18,000 square meters of fully automatic three-dimensional warehouses for storage and transportation, and 14,830 cubic meters of constant temperature and humidity cold storage warehouses.
The average daily throughput of the warehouse is more than 6,500
Latest news
During the Spring Festival, they stick to their jobs to ensure the delivery of emergency medicine
Original title: During the Spring Festival, they stick […]
Icing on the cake, new members have joined Liaoning Provincial Platform, Shanghai Pharmaceutical Group
Following Shanghai Pharmaceutical Group(Faku) Pharmaceu […]
Shanghai Pharma Third Quarterly Results: Net profit Attributable to Shareholders after Deduction of Non-recurring Profit or Loss Up by Nearly 20%, with Revenue from Pharmaceutical Manufacturing and Profit Growing over 20% once more
Shanghai, On 30 October 2019, Shanghai Pharmaceuticals […]
Business scope
Main business
Our company is a comprehensive pharmaceutical distribution enterprise that integrates various business formats, such as pharmaceutical sales, device distribution and sales, e-commerce, in-depth promotion, import and export business, supply chain services, logistics services, emerging businesses and so on. The varieties of medicines inland are mainly imported medicines and joint-venture medicines. Export business mainly involves pharmaceutical raw materials, intermediates, chemical raw materials and other products.
Cooperation partner
Our company now has more than 200 suppliers in China, and cooperates with the world's top 100 foreign and joint-venture pharmaceutical suppliers, including Bayer, AstraZeneca, Sanofi, Pfizer, Novartis, Novo Nordisk, Roche, Merck Serono, Boehringer and Eli Lilly have established long-term and reliable cooperative relations in order to create a mutually beneficial ecosystem.
Network coverage
The sales network inland is centered on Liaoning, as well as covers the three eastern provinces and Inner Mongolia which form a perfect market network structure. At the same time, the commercial scope covers 705 hospitals of different grades, 1,259 primary medical institutions and 936 retail terminals. The international market has established stable business relationships with more than 100 customers from more than 20 countries and regions.
